Please confirm you are human (Sign Up for free to never see this)
← Back to Search
More Satisfied, But Why? A Pooled Patient‐level Analysis Of Treatment Satisfaction Following The Initiation Of Insulin Glargine Vs. Comparators In Insulin‐naïve Patients With Type 2 Diabetes Mellitus
W. Polonsky, L. Traylor, W. Wei, R. Shi, B. Ameer, A. Vlajnic, A. Nicolucci
Published 2014 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
To assess patient‐reported outcomes associated with initiating insulin glargine among insulin‐naïve patients with type 2 diabetes mellitus (T2DM).
This paper references
Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.
S. Nakar (2007)
RECOMMANDATIONS 2012 EN DIABÉTOLOGIE: Prise en charge de l'hyperglycémie dans le diabète de type 2: une approche centrée sur le patient
A. Scheen (2012)
Diabetes Treatment Satisfaction Questionnaire: (DTSQ)
C. Bradley (2013)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. Inzucchi (2012)
Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: the Canadian INSIGHT Study.
R. Houlden (2007)
Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.
M. Peyrot (2005)
Improving treatment satisfaction and other patient‐reported outcomes in people with type 2 diabetes: the role of once‐daily insulin glargine
C. Bradley (2008)
Quality of Life in Type 2 Diabetic Patients
A. Spasić (1999)
Primary care physician beliefs about insulin initiation in patients with type 2 diabetes
R. Hayes (2008)
Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.
W. Polonsky (2005)
Initiate Insulin by Aggressive Titration and Education (INITIATE): A randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups
J. Leahy (2008)
Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population
William H. Polonsky (2011)
Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health‐related quality of life. A prospective cohort study in primary care
T. Hajós (2011)
Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur.
C. Bradley (1999)
Well-Being and Symptoms in Relation to Insulin Therapy in Type 2 Diabetes
J. J. J. D. Sonnaville (1998)
10-year follow-up of intensive glucose control in type 2 diabetes.
R. Holman (2008)
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes
C. Currie (2006)
Handbook of Psychology and Diabetes : A Guide to Psychological Measurement in Diabetes Research and Practice
C. Bradley (1994)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
UK Prospective Diabetes Study Group (1998)
Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study.
T. Davis (2001)
Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.
H. Janka (2005)
The study group.
G. H. Duvel (1980)
Effect of Intensive Glycemic Lowering on Health-Related Quality of Life in Type 2 Diabetes
R. Anderson (2011)
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
M. Riddle (2003)
Improvements in quality of life associated with insulin analogue therapies in people with type 2 diabetes: results from the A1chieve observational study.
S. Shah (2011)
Study (UKPDS) Group
UK Prospective Diabete (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
R. Turner (1998)
Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study
N. Hermanns (2010)
Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.
S. Chatterjee (2007)
The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ
C. Bradley (2007)
The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study*
J. S. Fischer (2004)
Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
MC Riddle (2003)
Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.
D. Marrero (2007)
Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: results from the durable trial.
L. J. Lee (2010)
This paper is referenced by
Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin
Albrecht Fiesselmann (2016)
Diabetes Flash Continuous Glucose Monitoring and its IMPACT to REPLACE Blood Glucose Monitoring in the Management of Type 1 and Type 2 Diabetes
S. Twigg (2017)
Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain.
D. Riebenfeld (2015)
Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study.
Mayuko Oita (2018)
Essential parameters and risk factors of the patients for diabetes care and treatment.
A. Bener (2017)
Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial
T. Takase (2019)
Benefits of timely basal insulin control in patients with type 2 diabetes.
Dragana Lovre (2015)